Angiosarcoma of Skin Clinical Trial
Official title:
A Phase II Study of Talimogene Laherparepvec (T-VEC) in the Treatment of Locally Advanced Cutaneous Angiosarcoma
This is a single-arm study evaluating the efficacy of injecting Talimogene Laherparepvec T-VEC into Cutaneous Angiosarcoma tumors.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03544567 -
A Study of Oraxol in Subjects With Cutaneous Angiosarcoma
|
Phase 2 |